Navigating the Complexities of Rare Disease

To be successful, rare disease studies need to be designed and run with the specific needs of the patients, their caretakers, and their medical providers in mind. Also essential is understanding the pathway of care and specifics of the disease. In short, you need a CRO with the expertise in rare disease research to get the job done right.

At Clinipace, our geographic footprint and right-size team can help ease your burden, which is important with such high-stakes trials. Not only do we have broad medical expertise in therapeutic areas with high instances of rare disease — like oncology and nephrology — but our flexible and fast-thinking team is well-equipped for creating novel solutions to meet any challenge across multiple indications, such as:

  • Multiple myeloma
  • Hepatocellular carcinoma
  • Leukemia (AML, CLL)
  • Lymphoma (B cell, SLL, mantle cell, DLBCL)
  • Mycosis fungoides
  • Lymphoproliferative disorder
  • Richter’s transformation
  • Crigler-Najjar syndrome
  • Myelodysplastic syndrome
  • Graft vs. host disease
  • Hemophilia
  • Enterovirus
  • Bird flu
  • Enterovirus EV71
  • Fibrinogen deficiency